Results 101 to 110 of about 4,323 (176)

Age-dependent diagnostic and treatment response prediction of TBII and TSI in Graves' orbitopathy: integration with orbital MRI biomarkers. [PDF]

Front Immunol
Song C, Wang X, Ma Q, Yu G, Zhu Y, Huang Z, Chen T, Huang K, Hai Y, Chen H, Duan Y, Shen J.   +11 more
europepmc   +1 more source

Nicotinamide N-Methyltransferase in the Inflammatory Pathogenesis of Graves' Orbitopathy. [PDF]

Invest Ophthalmol Vis Sci
Cho D, Choi SH, Yoon JS, Ko J.
europepmc   +1 more source

Role of SerpinA3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts. [PDF]

Invest Ophthalmol Vis Sci
Kim MS, Choi SH, Park HY, Jang SY, Ko J, Kim JW, Yoon JS.   +6 more
europepmc   +1 more source

Current concepts of tocilizumab efficacy in active moderate-to-severe corticosteroid-resistant cases of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Boutzios G, Nikolopoulou A, Chatzi S, Tzioufas AG, Goules AV.   +4 more
europepmc   +1 more source

Clinical Impact of Radiotherapy in Steroid-Refractory Graves' Orbitopathy. [PDF]

Cureus
Escobar Peralta E, García Ramírez JM, Ordoñez CHH, Bautista Hernández MY.   +3 more
europepmc   +1 more source

Effects of pulse glucocorticoid treatment on retinal blood flow in patients with active Graves' orbitopathy. [PDF]

BMC Ophthalmol
Mohammadi H, Güneş İB, Arı Ş.
europepmc   +1 more source

A randomized controlled trial on the effect of hydroxychloroquine in mild Graves' orbitopathy (GO-HCQ): study protocol. [PDF]

Trials
Lin CH, Wei YH, Lu JY, Li HY, Lee CW, Yang CY, Chang CH, Wu WC, Wang CY, Shih SR.   +9 more
europepmc   +1 more source

Role of genetics and epigenetics in Graves' orbitopathy. [PDF]

Eur Thyroid J
Marinò M, Rotondo Dottore G, Menconi F, Comi S, Cosentino G, Rocchi R, Latrofa F, Figus M, Santini F.   +8 more
europepmc   +1 more source

Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim W, Seo MK, Kim YJ, Choi SH, Ku CR, Kim S, Lee EJ, Yoon JS.   +7 more
europepmc   +1 more source

MMP14 as a central mediator of TGF-β1-induced extracellular matrix remodeling in graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Wang X, Lu J, He Y, Shu Q, Lin Y, Su W, Wang P.   +6 more
europepmc   +1 more source